Thus, pharmacologic or other approaches that could modulate macrophage activity and IL-4/IL-6 production in the adipose tissue during aging could be exploited therapeutically in the recovery of beige fat to potentially improve metabolic health, as been done in the field of obesity (38, 39). The gene discussed is IL6; the disease is obesity disorder.